Pamir Ozan bought NAGE
February 19, 2026 · Form 4 insider transaction
Pamir Ozan bought 62,131 shares of Niagen Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
62,131
Price
$0.00
Total value
N/A
InsiderPamir Ozan
Role—
SecurityEmployee Stock Options (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2026
Filing dateFebruary 24, 2026
Shares owned after62,131
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-fourth of the shares subject to the option shall vest on each anniversary of the grant date.